|
CO-ADMINISTRATION MAY INTERFERE WITH THE BENEFITS OF ASPIRIN TAKEN FOR HEART DISEASE, SHOULD BE TAKEN ON DIFFERENT TIMES
|
PARACETAMOL DEVELOPED SEVERE HEPATOTOXICITY
|
PARACETAMOL ABSORPTION IS INCREASED
|
INCREASED RISK OF NEPHROTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
INCREASES RISK OF HEPATOTOXICITY
|
CHOLESTYRAMINE REDUCES ABSORPTION IF GIVEN WITHIN ONE HOUR OF EACH OTHER ORALLY, SO IT SHOULD BE GIVEN EITHER ATLEAST 1 HR BEFORE OR 4-6 HRS AFTER CHOLESTYRAMINE
|
CHOLESTYRAMINE REDUCES ABSORPTION IF GIVEN WITHIN ONE HOUR OF EACH OTHER ORALLY, SO IT SHOULD BE GIVEN EITHER ATLEAST 1 HR BEFORE OR 4-6 HRS AFTER CHOLESTYRAMINE
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
PROBENECID INCREASES THE SERUM LEVELS OF THE DRUG
|
DOMPERIDONE INCREASES ABSORPTION OF THE DRUG
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL TOXICITY RISK ARE INCREASED BY TWO FOLD IF GIVEN WITH DRUGS THAT INDUCE LIVER MICROSOMAL ENZYMES
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PARACETAMOL HAS BEEN FOUND TO ENHANCE THE ANTIVIRAL EFFECTS OF INTERFERON
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|
PROGESTERONES ENHANCES PLASMA CLEARANCE OF THE DRUG
|